Product image coming soon
Retatrutide (Reta)
10mg
Triple-agonist GLP-1/GIP/GCGR peptide for advanced metabolic research.
- Dosage
- 10mg
- Purity
- ≥ 98% (HPLC tested)
- Form
- Lyophilized Powder
- SKU
- VLT-RETA-10
- Kit Contents
- 10mg sterile lyophilized powder vial
Retatrutide is an absolute pinnacle in modern metabolic and obesity research. It represents a single peptide chain engineered to act as a Triple Agonist targeting three distinct metabolic receptors: GLP-1 (Glucagon-Like Peptide-1), GIP (Gastric Inhibitory Polypeptide), and GCGR (Glucagon Receptor). While older agents only target GLP-1, Retatrutide's triple-action mechanism completely alters metabolic rate. The GLP-1 and GIP components cause delayed gastric emptying and signal intense satiety to the brain, while the Glucagon receptor agonist component upregulates energy expenditure and thermogenesis directly inside liver cells.
